Brokers Offer Predictions for Vivani Medical FY2024 Earnings

Vivani Medical, Inc. (NASDAQ:VANI) – HC Wainwright dropped their FY2024 earnings per share (EPS) estimates for Vivani Medical in a note issued to investors on Thursday, March 13th. HC Wainwright analyst Y. Chen now forecasts that the company will post earnings of ($0.43) per share for the year, down from their prior forecast of ($0.41). HC Wainwright has a “Buy” rating and a $4.00 price objective on the stock. The consensus estimate for Vivani Medical’s current full-year earnings is ($0.41) per share. HC Wainwright also issued estimates for Vivani Medical’s Q1 2025 earnings at ($0.10) EPS, Q3 2025 earnings at ($0.09) EPS, Q4 2025 earnings at ($0.09) EPS and FY2025 earnings at ($0.39) EPS.

Vivani Medical Trading Up 2.8 %

NASDAQ:VANI opened at $1.09 on Monday. The stock’s 50-day moving average is $1.16 and its 200-day moving average is $1.22. Vivani Medical has a 1-year low of $1.03 and a 1-year high of $2.22. The stock has a market cap of $64.57 million, a P/E ratio of -2.42 and a beta of 3.20.

Hedge Funds Weigh In On Vivani Medical

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Geode Capital Management LLC grew its stake in shares of Vivani Medical by 4.6% in the third quarter. Geode Capital Management LLC now owns 342,891 shares of the company’s stock worth $401,000 after purchasing an additional 15,008 shares during the last quarter. Northern Trust Corp grew its position in shares of Vivani Medical by 19.1% in the 4th quarter. Northern Trust Corp now owns 71,915 shares of the company’s stock valued at $83,000 after buying an additional 11,540 shares during the last quarter. Jane Street Group LLC acquired a new stake in shares of Vivani Medical in the fourth quarter valued at about $66,000. Finally, Wealthedge Investment Advisors LLC bought a new position in shares of Vivani Medical during the fourth quarter worth about $43,000. 6.78% of the stock is currently owned by institutional investors and hedge funds.

Vivani Medical Company Profile

Vivani Medical, Inc, a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals.